Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 20,160 | 49,260 | 51,226 | 73,368 | 70,553 |
| Operating Income | -20,160 | -49,260 | -51,226 | -73,368 | -70,553 |
| Interest Expense | 0 | 11,414 | 11,571 | 7,194 | 4,880 |
| Other Income | 1,000 | 1,592 | 505 | 28 | 1,199 |
| Pre-tax Income | -19,160 | -59,082 | -62,292 | -80,534 | -74,234 |
| Income Tax | -203 | N/A | -70 | N/A | -16 |
| Net Income Continuous | -18,957 | -59,082 | -62,222 | -80,534 | -74,218 |
| Net Income | $-18,957 | $-59,082 | $-62,222 | $-80,534 | $-74,218 |
| EPS Basic Total Ops | -0.34 | -1.33 | -2.30 | -3.12 | -2.98 |
| EPS Basic Continuous Ops | -0.35 | -1.33 | -2.30 | -3.12 | -2.98 |
| EPS Diluted Total Ops | -0.34 | -1.33 | -2.30 | -3.12 | -2.98 |
| EPS Diluted Continuous Ops | -0.35 | -1.33 | -2.30 | -3.12 | -2.98 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -1.33 | -2.30 | -3.12 | -2.98 |
| EBITDA(a) | $-20,140 | $-49,001 | $-51,112 | $-72,590 | $-70,185 |